Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Sara Storvall"'
Autor:
Sara Storvall, Helena Leijon, Eeva Ryhänen, Johanna Louhimo, Caj Haglund, Camilla Schalin-Jäntti, Johanna Arola
Publikováno v:
Endocrine Connections, Vol 8, Iss 8, Pp 1213-1223 (2019)
Introduction: Parathyroid carcinoma represents a rare cause of primary hyperparathyroidism. Distinguishing carcinoma from the benign tumors underlying primary hyperparathyroidism remains challenging. The diagnostic criteria for parathyroid carcinoma
Externí odkaz:
https://doaj.org/article/ffa61f5b6fce42b4965e0bddb5c78075
Publikováno v:
Cancers
Volume 15
Issue 5
Pages: 1405
Volume 15
Issue 5
Pages: 1405
Parathyroid tumors are mostly sporadic but can also occur in familial forms, including different kinds of genetic syndromes with varying phenotypes and penetrance. Recently, somatic mutations of the tumor suppressor gene PRUNE2 were found to be frequ
Autor:
Sara, Storvall, Helena, Leijon, Eeva M, Ryhänen, Tiina, Vesterinen, Ilkka, Heiskanen, Camilla, Schalin-Jäntti, Johanna, Arola
Publikováno v:
European journal of endocrinology. 185(6)
Parathyroid carcinoma (PC), atypical parathyroid tumours (APT) and parathyroid adenoma (PA), all present with hypercalcemia. Diminished calcium-sensing receptor (CaSR) expression is reported in PC but is rare in benign tumours. Filamin A (FLNA) binds
Autor:
Eeva Ryhänen, Johanna Louhimo, Caj Haglund, Johanna Arola, Helena Leijon, Sara Storvall, Camilla Schalin-Jäntti
Publikováno v:
Endocrine Connections, Vol 8, Iss 8, Pp 1213-1223 (2019)
Endocrine Connections
Endocrine Connections
Introduction Parathyroid carcinoma represents a rare cause of primary hyperparathyroidism. Distinguishing carcinoma from the benign tumors underlying primary hyperparathyroidism remains challenging. The diagnostic criteria for parathyroid carcinoma a
Autor:
Camilla Schalin-Jäntti, Tiina Vesterinen, Eeva Ryhänen, Ilkka Heiskanen, Johanna Arola, Jukka Schildt, Auli Karhu, Sara Storvall, Soili Kytölä, Frank V. Bensch
Publikováno v:
Journal of the Endocrine Society
Context Parathyroid carcinoma (PC) is extremely rare. Prognosis is poor, with no known evidence-based systemic therapies. We previously reported complete remission in a patient with metastasized parathyroid carcinoma and high tumor MGMT promoter meth
Autor:
Harri Sintonen, Eeva Ryhänen, Risto P. Roine, Ilkka Heiskanen, Sara Storvall, Camilla Schalin-Jäntti
Publikováno v:
Hormone and Metabolic Research. 49:772-777
Surgery for primary hyperparathyroidism (PHPT) improves health-related quality of life (HRQoL), but it is unclear whether the effects are sustained after medium-term (>2 years) follow-up, and whether the results on some or all dimensions of HRQoL wil
Autor:
Johanna Arola, Camilla Schalin-Jäntti, Caj Haglund, Eeva M. Ryhänen, Johanna Louhimo, Sara Storvall, Helena Leijon
Publikováno v:
Endocrine Abstracts.
Autor:
Ilkka Heiskanen, Sara Storvall, Camilla Schalin-Jäntti, Eeva Ryhänen, Siru Mäkelä, Tapani Ebeling, Soili Kytölä, Frank V. Bensch
Publikováno v:
JBMR Plus. 3:e10114
Parathyroid carcinoma is a rare cause of primary hyperparathyroidism with rather poor prognosis. Apart from surgery, no evidence-based treatments exist. A 48-year-old woman presented with weight loss, nausea, constipation, hypercalcemic crisis, and a